Kinase Inhibitors

InformationGeldanamycin (NSC 122750) Geldanamycin (NSC 122750) is a natural existing HSP90 inhibitor with K d of 1.2 μM, specifically disrupts glucocorticoid receptor (GR)/HSP association. Geldanamycin attenuates virus infection-induced ALI (acute

Genistein is a nutraceutical isoflavnoid from soybean and is a phytoestrogen. It is derived from genistin.

Genistein is a nutraceutical isoflavnoid from soybean and is a phytoestrogen. It is derived from genistin.

Genz-123346 (free base) is an inhibitor of GL1 synthase that blocks the conversion of ceramide to GL1: inhibits GM1 with IC50 value of 14 nM. IC50: 14 nM (GM1)Exposure of cells to Genz-123346 and to other GCS inhibitors at nontoxic concentrations

Genz-123346 (free base) is an inhibitor of GL1 synthase that blocks the conversion of ceramide to GL1: inhibits GM1 with IC50 value of 14 nM. IC50: 14 nM (GM1)Exposure of cells to Genz-123346 and to other GCS inhibitors at nontoxic concentrations

Genz-123346 (free base) is an inhibitor of GL1 synthase that blocks the conversion of ceramide to GL1: inhibits GM1 with IC50 value of 14 nM. IC50: 14 nM (GM1)Exposure of cells to Genz-123346 and to other GCS inhibitors at nontoxic concentrations

Genz-123346 (free base) is an inhibitor of GL1 synthase that blocks the conversion of ceramide to GL1: inhibits GM1 with IC50 value of 14 nM. IC50: 14 nM (GM1)Exposure of cells to Genz-123346 and to other GCS inhibitors at nontoxic concentrations

Genz-123346 (free base) is an inhibitor of GL1 synthase that blocks the conversion of ceramide to GL1: inhibits GM1 with IC50 value of 14 nM. IC50: 14 nM (GM1)Exposure of cells to Genz-123346 and to other GCS inhibitors at nontoxic concentrations

Application GF 109203X has been used as a protein kinase C inhibitor in HUVECs (human umbilical vein endothelial cells), angiotensinogen gene knockout (AGT KO) mice, and in granulosa cell cultures of female rats. Biochem/physiol Actions A potent

Application GGTI 298 trifluoroacetate salt hydrate has been used as a geranylgeranyltransferase I (GGTase I) inhibitor: to study the anticancer effects of statins along with GGTI 298 to study its combinatorial effects with FTI-277 on

Application GGTI 298 trifluoroacetate salt hydrate has been used as a geranylgeranyltransferase I (GGTase I) inhibitor: to study the anticancer effects of statins along with GGTI 298 to study its combinatorial effects with FTI-277 on

Inhibitors of mycobacterial serine/threonine protein kinases: inhibitors of protein kinases, e.g. Mycobacterium tuberculosis protein kinase G.:.